Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | thyroid hormone receptor, beta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Brugia malayi | photoreceptor-specific nuclear receptor | thyroid hormone receptor, beta | 461 aa | 414 aa | 24.6 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0 | 0.5 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0152 | 0.7734 | 0.7734 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2544 | 0.2544 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.2544 | 0.2675 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.1028 | 0.1081 |
Schistosoma mansoni | alpha-glucosidase | 0.0153 | 0.7808 | 0.7808 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0719 | 0.0719 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2544 | 0.2544 |
Schistosoma mansoni | alpha-glucosidase | 0.0153 | 0.7808 | 0.7808 |
Brugia malayi | RNA binding protein | 0.0076 | 0.2544 | 0.2675 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0039 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.2544 | 0.2675 |
Trypanosoma brucei | glucosidase, putative | 0.0039 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0719 | 0.0719 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0178 | 0.951 | 0.951 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2544 | 0.2544 |
Schistosoma mansoni | hypothetical protein | 0.0152 | 0.7734 | 0.7734 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0054 | 0.1028 | 0.1081 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.2544 | 0.2544 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0719 | 0.0719 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0178 | 0.951 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.2544 | 0.2675 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.0719 | 0.0756 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2544 | 0.2544 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.2544 | 0.2675 |
Echinococcus multilocularis | geminin | 0.0185 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0054 | 0.1028 | 0.1081 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.2544 | 0.2675 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.0719 | 0.0756 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0178 | 0.951 | 0.951 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 1 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0178 | 0.951 | 0.951 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.2544 | 0.2544 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0178 | 0.951 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.2544 | 0.2544 |
Onchocerca volvulus | 0.0103 | 0.4357 | 0.5 | |
Leishmania major | alpha glucosidase II subunit, putative | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0175 | 0.9331 | 0.9331 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0039 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0 | 0.5 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0719 | 0.0719 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0 | 0.5 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0039 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0054 | 0.1028 | 0.1081 |
Schistosoma mansoni | thyroid hormone receptor | 0.0175 | 0.9331 | 0.9331 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0152 | 0.7734 | 0.7734 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0175 | 0.9331 | 0.9331 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0719 | 0.0719 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0719 | 0.0719 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0719 | 0.0719 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.0025 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 0.8913 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.